
US markets look past near-term Covid-19 anxiety to brighter pastures in 2022.
20:24, 30 December 2021

The treatment is less effective than Pfizer’s that was approved a day earlier.
22:06, 23 December 2021
William Hoffman is a senior reporter for Capital.com. He previously covered investment grade corporate bonds for International Financing Review (IFR), a division of Refinitiv and the London Stock Exchange. He has also written for trade publications covering auto finance and the confectionary industry.
US markets look past near-term Covid-19 anxiety to brighter pastures in 2022.
The treatment is less effective than Pfizer’s that was approved a day earlier.
Join the 500.000+ traders worldwide that chose to trade with Capital.com